Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Arm and Phase II Clinical Trial of a Sandwich Regimen as XELOX Regimen and Capecitabine Alternate Administration Combined With Preoperative Intensity Modulated Radiation Therapy for pMMR Locally Advanced Rectal Cancer

NCT05228431 is registered in ClinicalTrials.gov with Zhen-Hai Lu as lead sponsor.

NCT NCT05228431
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05228431 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Arm and Phase II Clinical Trial of a Sandwich Regimen as XELOX Regimen and Capecitabine Alternate Administration Combined With Preoperative Intensity Modulated Radiation Therapy for pMMR Locally Advanced Rectal Cancer
Lead sponsor
Zhen-Hai Lu
Phase
Phase 2
Overall status
Recruiting
Start date
March 2, 2022
Completion date
May 1, 2028
Enrollment
121 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced rectal cancer